Evidence map›Paper›PMID 21718591›Full record

ReviewChinese journal of cancer2011

Mouse models of colorectal cancer.

Yunguang Tong, Wancai Yang, H Phillip Koeffler

Abstract readReview
In one paragraph

Review in Chinese journal of cancer, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Association between Broad-Spectrum Antibiotic Use and Risk of Early-Onset Colorectal Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. The Dynamic Changes of Gut Microbiota inInternational journal of molecular sciences · 2018
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yunguang TongDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. tongy@cshs.org
Wancai Yang
H Phillip Koeffler

Funding

Intestinal Cancer Chemoprevention: Molecular MechanismsR01CA112081 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI YANG, WANCAI · 2005 to 2009
$1.1M
PTTG1 regulates anti-cancer drug responseK99CA138914 · NCI · CEDARS-SINAI MEDICAL CENTER · PI TONG, YUNGUANG · 2010 to 2011
$324k
NCI NIH HHS CA112081NCI NIH HHS K99 CA138914NCI NIH HHS R01CA02603831NCI NIH HHS R01 CA112081
6 · The paper itself

Abstract

Colorectal cancer is one of the most common malignancies in the world. Many mouse models have been developed to evaluate features of colorectal cancer in humans. These can be grouped into genetically-engineered, chemically-induced, and inoculated models. However, none recapitulates all of the characteristics of human colorectal cancer. It is critical to use a specific mouse model to address a particular research question. Here, we review commonly used mouse models for human colorectal cancer.

Indexed as

Colorectal NeoplasmsDisease Models, AnimalGenetic EngineeringAdenomatous Polyposis ColiAnimalsColorectal Neoplasms, Hereditary NonpolyposisHumansInflammationMiceMice, TransgenicNeoplasm Metastasis

Identifiers

PMID21718591
PMCPMC4013420

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.